FDA issues nationwide recall of blood pressure pills after they fail quality tests
FDA issues nationwide recall of blood pressure pills after they fail quality tests
FDA issues nationwide recall of blood pressure pills after they fail quality tests
Key points
اہم نکات
मुख्य बातें
- The US Food and Drug Administration has issued a nationwide recall of thousands of bottles of a prescription blood pressure medicine after the pills failed quality testing.
- Macleods Pharma USA recalled 3,744 bottles of olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets, a generic version of the brand-name drug Tribenzor.
- The recall covers two lots, 12251163A in 30-tablet bottles and 12251163B in 90-tablet bottles, both expiring on May 31, 2027.
- The US Food and Drug Administration has issued a nationwide recall of thousands of bottles of a prescription blood pressure medicine after the pills failed quality testing.
- Macleods Pharma USA recalled 3,744 bottles of olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets, a generic version of the brand-name drug Tribenzor.
- The recall covers two lots, 12251163A in 30-tablet bottles and 12251163B in 90-tablet bottles, both expiring on May 31, 2027.
- The US Food and Drug Administration has issued a nationwide recall of thousands of bottles of a prescription blood pressure medicine after the pills failed quality testing.
- Macleods Pharma USA recalled 3,744 bottles of olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets, a generic version of the brand-name drug Tribenzor.
- The recall covers two lots, 12251163A in 30-tablet bottles and 12251163B in 90-tablet bottles, both expiring on May 31, 2027.
The US Food and Drug Administration has issued a nationwide recall of thousands of bottles of a prescription blood pressure medicine after the pills failed quality testing. Macleods Pharma USA recalled 3,744 bottles of olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets, a generic version of the brand-name drug Tribenzor. The recall covers two lots, 12251163A in 30-tablet bottles and 12251163B in 90-tablet bottles, both expiring on May 31, 2027. The tablets failed dissolution tests, meaning they may not release their medicine in the body as intended and may not control blood pressure properly. The FDA classed the recall as Class II on October 26. Patients who take the medicine should check the lot number on their bottle and speak to their doctor or pharmacist.
The US Food and Drug Administration has issued a nationwide recall of thousands of bottles of a prescription blood pressure medicine after the pills failed quality testing. Macleods Pharma USA recalled 3,744 bottles of olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets, a generic version of the brand-name drug Tribenzor. The recall covers two lots, 12251163A in 30-tablet bottles and 12251163B in 90-tablet bottles, both expiring on May 31, 2027. The tablets failed dissolution tests, meaning they may not release their medicine in the body as intended and may not control blood pressure properly. The FDA classed the recall as Class II on October 26. Patients who take the medicine should check the lot number on their bottle and speak to their doctor or pharmacist.
The US Food and Drug Administration has issued a nationwide recall of thousands of bottles of a prescription blood pressure medicine after the pills failed quality testing. Macleods Pharma USA recalled 3,744 bottles of olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets, a generic version of the brand-name drug Tribenzor. The recall covers two lots, 12251163A in 30-tablet bottles and 12251163B in 90-tablet bottles, both expiring on May 31, 2027. The tablets failed dissolution tests, meaning they may not release their medicine in the body as intended and may not control blood pressure properly. The FDA classed the recall as Class II on October 26. Patients who take the medicine should check the lot number on their bottle and speak to their doctor or pharmacist.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।